Plant Comparison

Hemp vs Willow Bark

A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.

First plant
Second plant
Show:
Plant AHempCannabis sativaCannabaceaeFull monograph →
Plant BWillow BarkSalix albaSalicaceaeFull monograph →

At a glance

Hemp and Willow Bark: they share 6 indicated uses (arthritis / joint pain, back pain, headache, …); 2 pharmacological actions in common.

HempWillow Bark
Constituents32
Pharmacological actions43
Indicated uses87
Safety notes22
Cited sources1913
Indicated uses
Only Hemp
Cardiovascular / heart healthInsomnia / sleeplessness
Shared (6)
Arthritis / joint painBack painHeadacheInflammation (general)Pain (general)Skin irritation
Only Willow Bark
Fever
Pharmacological actions
Only Hemp
AntioxidantSedative / sleep support
Shared (2)
Analgesic (pain relief)Anti-inflammatory
Only Willow Bark
Antipyretic (reduces fever)

Evidence face-off — shared uses

ConditionHempWillow BarkVerdict
Arthritis / joint pain5/107/10Stronger for Willow Bark
Back pain5/109/10Stronger for Willow Bark
Headache5/101/10Stronger for Hemp
Inflammation (general)5/108/10Stronger for Willow Bark
Pain (general)5/109/10Stronger for Willow Bark
Skin irritation5/108/10Stronger for Willow Bark

Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.

Key Constituents

Cannabinoids (THC, CBD and related compounds)[14, 15]

The characteristic bioactive compounds of the resin-bearing flowers, varying widely in ratio and concentration between cultivars; THC is psychoactive, CBD is not.

Terpenes[14]

Aromatic terpenes contribute to the plant's characteristic scent and may modulate cannabinoid effects.

Terpenes / terpenoidsEssential (volatile) oil
Seed oil fatty acids[14]

Hemp seed is rich in polyunsaturated fatty acids (including omega-3 and omega-6), giving the pressed seed oil its nutritional value; essentially free of psychoactive cannabinoids.

Salicin and related salicylates[1, 2, 6, 7, 11, 12]

Metabolised in the body to salicylic acid - the 'natural aspirin' that gives the analgesic, anti-inflammatory and antipyretic effects.

Salicin
Polyphenols, flavonoids and tannins[10, 12]

Contribute additionally to the anti-inflammatory and antioxidant activity.

Phenolic compoundsFlavonoidsTannins

Pharmacological Actions

Analgesic (pain relief)[1, 7, 9, 12, 14, 15, 16]
Anti-inflammatory[6, 8, 10, 12, 14, 15, 16]
Antioxidant[5, 14, 15, 16]
Sedative / sleep support[14, 15, 16]
Analgesic (pain relief)[1, 8, 9, 11, 12, 13]

Analgesic and anti-inflammatory for low back pain (moderate evidence; dose-dependent, around 240 mg salicin/day) - in an RCT, 240 mg salicin/day left 39% pain-free vs 6% on placebo within 4 weeks

Anti-inflammatory[1, 4, 11, 12, 13]

Analgesic and anti-inflammatory for low back pain (moderate evidence; dose-dependent, around 240 mg salicin/day) - in an RCT, 240 mg salicin/day left 39% pain-free vs 6% on placebo within 4 weeks

Antipyretic (reduces fever)[12]

Antipyretic (reduces fever)

Traditional & Indicated Uses

Arthritis / joint pain[14, 15, 16]Moderate · 5/10

inferred from anti-inflammatory action

Evidence: 5
Label: Arthritis / joint pain
Back pain[14, 15, 16]Moderate · 5/10

inferred from analgesic action

Evidence: 5
Label: Back pain
Cardiovascular / heart health[14, 15, 16]Moderate · 5/10
Evidence: 5
Label: Cardiovascular / heart health
Headache[14, 15, 16]Moderate · 5/10

inferred from analgesic action

Evidence: 5
Label: Headache
Inflammation (general)[14, 15, 16]Moderate · 5/10

inferred from anti-inflammatory action

Evidence: 5
Label: Inflammation (general)
Insomnia / sleeplessness[14, 15, 16]Moderate · 5/10

inferred from sedative action

Evidence: 5
Label: Insomnia / sleeplessness
Pain (general)[14, 15, 16]Moderate · 5/10
Evidence: 5
Label: Pain (general)
Skin irritation[14, 15, 16]Moderate · 5/10

inferred from anti-inflammatory action

Evidence: 5
Label: Skin irritation
Arthritis / joint pain[11, 12]Good · 7/10

Relief of joint pain, osteoarthritis and rheumatic complaints

Evidence: 7
Label: Arthritis / joint pain
Back pain[8, 9, 11, 12, 13]Strong · 9/10

Analgesic and anti-inflammatory for low back pain (moderate evidence; dose-dependent, around 240 mg salicin/day) - in an RCT, 240 mg salicin/day left 39% pain-free vs 6% on placebo within 4 weeks

Evidence: 9
Label: Back pain
Fever[12]Traditional · 1/10

Antipyretic (reduces fever)

Evidence: 1
Label: Fever
Headache[12]Traditional · 1/10
Evidence: 1
Label: Headache
Inflammation (general)[11, 12, 13]Good · 8/10

inferred from anti-inflammatory action

Evidence: 8
Label: Inflammation (general)
Pain (general)[8, 11, 12, 13]Strong · 9/10

Analgesic and anti-inflammatory for low back pain (moderate evidence; dose-dependent, around 240 mg salicin/day) - in an RCT, 240 mg salicin/day left 39% pain-free vs 6% on placebo within 4 weeks; Relief of joint pain, osteoarthritis and rheumatic complaints

Evidence: 9
Label: Pain (general)
Skin irritation[11, 12, 13]Good · 8/10

inferred from anti-inflammatory action

Evidence: 8
Label: Skin irritation

Safety, Cautions & Contraindications

Safety note[14, 15, 16]Caution

Industrial hemp (low-THC cannabis) seed oil and seeds are generally safe as food. CBD products derived from hemp may interact with medications metabolised by cytochrome P450 liver enzymes, including common anticoagulants, antiepileptics, and immunosuppressants. THC-containing preparations impair driving and are regulated or prohibited in many jurisdictions. Not recommended during pregnancy or breastfeeding. Quality and cannabinoid content vary widely between hemp products.

Safety note[14, 15, 16, 17]Caution

Duke (2002) rates cannabis as ++ and notes clinical evidence (score 2) for its antiemetic activity, especially relevant for chemotherapy-induced nausea. Score 1 activities include analgesic, anticonvulsant, and anti-inflammatory properties. Duke highlights the legal and pharmacological complexity, noting THC as the primary psychoactive compound. Medically, synthetic cannabinoids (dronabinol, nabilone) are clinically approved for nausea and anorexia. Duke cautions that while the plant has genuine therapeutic potential, psychoactive effects, legal restrictions, and risk of dependence with regular use must be considered (Duke, 2002).

Safety note[12]Caution

Because it works like aspirin, avoid willow bark if you are allergic to aspirin or salicylates, and do NOT give it to children or teenagers with a viral illness (risk of Reye's syndrome). Use caution in asthma (salicylate sensitivity).

Safety note[12]Caution

Avoid with anticoagulant/antiplatelet medicines (bleeding risk) and in active peptic ulcer; avoid in pregnancy (especially the third trimester) and breastfeeding.

External Ids

Gbif: 5361880
Wikidata: Q26726
Wikidata: Q156918

Botanical Description

Erect annual herb with a distinctive palmately compound leaf of narrow, serrated leaflets. The plant is usually dioecious (separate male and female plants); female plants develop dense, resinous flower clusters, while male plants bear looser pollen-releasing flowers. The seed (achene) is small, hard-shelled and oil-rich.[14]

Height: 1-5 m, depending on variety and cultivation
Habit: Erect, fast-growing annual herb
Leaves: Palmately compound, narrow serrated leaflets
Flowers: Dioecious; female flowers in dense resinous clusters, male flowers looser and pollen-releasing
Stem: Erect, fibrous, often ridged
Root: Taproot with fibrous lateral roots
Fruit: Small, hard-shelled, oil-rich achene (seed)
Flowering Period: Late summer to autumn

Large deciduous tree (Salicaceae), 10-25 m tall (occasionally taller), fast-growing with a broad crown. Leaves are narrow and lance-shaped, silvery-white and silky-hairy beneath, giving the tree a shimmering appearance in the wind. Tiny flowers are borne in catkins appearing with the leaves in spring; the species is dioecious. The fruit is a small capsule releasing cottony-tufted seeds.[12]

Height: 10-25 m
Habit: Large, fast-growing deciduous tree, dioecious
Leaves: Narrow, lance-shaped, silvery-white and silky-hairy beneath
Flowers: Tiny, in catkins with the leaves
Stem: Broad-crowned trunk
Root: Extensive, water-seeking root system
Fruit: Small capsule with cottony-tufted seeds
Flowering Period: April-May

Habitat

Believed native to Central Asia; now cultivated worldwide, with industrial hemp (low-THC cultivars) grown in temperate climates for fibre, seed and cannabinoid extraction, subject to varying legal regulation by jurisdiction.[14]

Native to Europe, western and central Asia and North Africa, growing on damp ground along riverbanks, floodplains and wet meadows; widely planted and naturalised elsewhere.[12]

Harvesting

Flowers (and resin-bearing leaves) are harvested at peak resin/cannabinoid content, typically as the flower clusters mature in late summer to autumn; seed is harvested once mature and dried, then pressed for oil or used whole.[14]

Parts: Flower, Leaf, Seed
Season: Late summer to autumn

Bark is stripped from young branches (2-3-year-old growth is preferred, as salicin content is highest in younger bark) in spring, when the rising sap makes the bark peel most easily, then dried.[12]

Parts: Bark
Season: Spring

Traditional Uses

Cannabis/hemp has a long multi-cultural history as a fibre, food and medicinal plant, traditionally used for pain, muscle spasm, sleep and appetite, alongside industrial use of the fibre and seed. Modern cannabinoid research, particularly on THC and CBD, has substantially expanded the evidence base for pain, spasticity and specific seizure disorders.[14, 15]

Willow bark has one of the longest documented histories of any medicinal plant, used since antiquity (recorded by Hippocrates) as a remedy for pain and fever. Its salicin content, chemically related to aspirin, gives it official European herbal-monograph recognition for mild joint pain, headache and feverish colds, with modern clinical trials supporting benefit for low back pain.[11, 12]

Preparations

Seed / seed oil[14]

Whole or hulled seed, or cold-pressed seed oil, used as a nutritional food source (essentially free of psychoactive cannabinoids).

Standardised cannabinoid extract[15]

Extract standardised to specific cannabinoid content (e.g. CBD), used in regulated medicinal products; regulatory status varies widely by jurisdiction and product type.

Decoction[12]

Dried bark simmered in water - the traditional preparation, since salicin needs proper simmering (not just a quick infusion) to extract well.

Standardised extract (capsule/tablet)[11]

Standardised to salicin content, the form used in clinical trials.

References

REF-0758, REF-0759, REF-0760, REF-2132, REF-2133, REF-2134, REF-2135, REF-2136, REF-2137, REF-2138, REF-2139, REF-2140, REF-2141
REF-1253, REF-1254, REF-1255, REF-1256, REF-1257, REF-1258, REF-1259, REF-1260, REF-1261, REF-1262

Drug Class Interactions

Safety note[18, 19]Caution
Drug Class: sedatives-cns-depressants
Mechanism: Cannabis (and CBD) commonly cause drowsiness and sedation; taken with sedatives, sleeping tablets, opioids or other central-nervous-system depressants (including alcohol) it may add to drowsiness and slowed reactions.
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-03
Safety note[18]Caution
Drug Class: anticonvulsants
Mechanism: Cannabidiol (CBD) interacts with anti-seizure medicines - notably raising exposure to clobazam - and can add to sedation; anyone combining cannabis/CBD with anticonvulsants should be monitored and doses reviewed by their clinician.
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-03

Not documented

Lookalikes Review

Outcome: none-known
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-07
Outcome: none-known
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-07

Dosage

Not documented

Standardised extract[11, 12]

Clinical trials for back pain have used around 240 mg salicin/day of standardised extract. Educational reference only, not a prescription; avoid if allergic to aspirin/salicylates, in children/teenagers with a viral illness (Reye's syndrome risk), or alongside anticoagulants.

References & Sources

  1. Rock, E.M. and Parker, L.A (2021) 'Constituents of Cannabis sativa', Advances in Experimental Medicine and Biology, 1264, pp. 1-13. doi:10.1007/978-3-030-57369-0_1 Traditional / reference
    https://doi.org/10.1007/978-3-030-57369-0_1
  2. Castillo-Arellano, J., Canseco-Alba, A., Cutler, S.J. and León, F (2023) 'The Polypharmacological Effects of Cannabidiol', Molecules, 28(7), pp. 3271. doi:10.3390/molecules28073271 Traditional / reference
    https://doi.org/10.3390/molecules28073271
  3. Pagano, C., Navarra, G., Coppola, L., Avilia, G. et al (2022) 'Cannabinoids: Therapeutic Use in Clinical Practice', International Journal of Molecular Sciences, 23(6), pp. 3344. doi:10.3390/ijms23063344 Traditional / reference
    https://doi.org/10.3390/ijms23063344
  4. ElSohly, M.A., Radwan, M.M., Gul, W., Chandra, S. and Galal, A (2017) 'Phytochemistry of Cannabis sativa L', Progress in the Chemistry of Organic Natural Products, 103, pp. 1-36. doi:10.1007/978-3-319-45541-9_1 Meta-analysis / review
    https://doi.org/10.1007/978-3-319-45541-9_1
  5. Viana, M.D.B., de Aquino, P.E.A., Estadella, D., Ribeiro, D.A. and Viana, G.S.D.B (2022) 'Cannabis sativa and cannabidiol: a therapeutic strategy for the treatment of neurodegenerative diseases?', Medical Cannabis and Cannabinoids, 5(1), pp. 207-219. doi:10.1159/000527335 Meta-analysis / review
    https://doi.org/10.1159/000527335
  6. Alves, P., Amaral, C., Teixeira, N. and Correia-da-Silva, G (2020) 'Cannabis sativa: much more beyond delta-9-tetrahydrocannabinol', Pharmacological Research, 157, pp. 104822. doi:10.1016/j.phrs.2020.104822 Meta-analysis / review
    https://doi.org/10.1016/j.phrs.2020.104822
  7. Odieka, A.E., Obuzor, G.U., Oyedeji, O.O., Gondwe, M., Hosu, Y.S. and Oyedeji, A.O (2022) 'The medicinal natural products of Cannabis sativa Linn.: a review', Molecules, 27(5), pp. 1689. doi:10.3390/molecules27051689 Meta-analysis / review
    https://doi.org/10.3390/molecules27051689
  8. Nuutinen, T (2018) 'Medicinal properties of terpenes found in Cannabis sativa and Humulus lupulus', European Journal of Medicinal Chemistry, 157, pp. 198-228. doi:10.1016/j.ejmech.2018.07.076 Meta-analysis / review
    https://doi.org/10.1016/j.ejmech.2018.07.076
  9. Liktor-Busa, E., Keresztes, A., LaVigne, J., Streicher, J.M. and Largent-Milnes, T.M (2021) 'Analgesic potential of terpenes derived from Cannabis sativa', Pharmacological Reviews, 73(4), pp. 98-126. doi:10.1124/pharmrev.120.000046 Meta-analysis / review
    https://doi.org/10.1124/pharmrev.120.000046
  10. Martinelli, G., Magnavacca, A., Fumagalli, M., Dell'Agli, M., Piazza, S. and Sangiovanni, E (2021) 'Cannabis sativa and skin health: dissecting the role of phytocannabinoids', Planta Medica, 88(7), pp. 492-506. doi:10.1055/a-1420-5780 Meta-analysis / review
    https://doi.org/10.1055/a-1420-5780
  11. Andre, C.M., Hausman, J.F. and Guerriero, G (2016) 'Cannabis sativa: the plant of the thousand and one molecules', Frontiers in Plant Science, 7, pp. 19. doi:10.3389/fpls.2016.00019 Meta-analysis / review
    https://doi.org/10.3389/fpls.2016.00019
  12. Bonini, S.A., Premoli, M., Tambaro, S., Kumar, A., Maccarinelli, G., Memo, M. and Mastinu, A (2018) 'Cannabis sativa: a comprehensive ethnopharmacological review of a medicinal plant with a long history', Journal of Ethnopharmacology, 227, pp. 300-315. doi:10.1016/j.jep.2018.09.004 Meta-analysis / review
    https://doi.org/10.1016/j.jep.2018.09.004
  13. Bergamaschi, M.M., Queiroz, R.H.C., Zuardi, A.W. and Crippa, J.A.S (2011) 'Safety and side effects of cannabidiol, a Cannabis sativa constituent', Current Drug Safety, 6(4), pp. 237-249. doi:10.2174/157488611798280924 Meta-analysis / review
    https://doi.org/10.2174/157488611798280924
  14. Cerino, P., Buonerba, C., Cannazza, G. et al (2021) 'A review of hemp as food and nutritional supplement', 6(1), pp. 19--27. doi:10.1089/can.2020.0001 Preclinical
    https://doi.org/10.1089/can.2020.0001
  15. Devinsky, O., Cross, J.H., Laux, L. et al (2017) 'Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome', 376(21), pp. 2011--2020. Randomized trial
    https://scholar.google.com/scholar?q=Trial%20of%20cannabidiol%20for%20drug-resistant%20seizures%20in%20the%20Dravet%20syndrome
  16. Royal Botanic Gardens, Kew (n.d.). Available at: https://powo.science.kew.org Traditional / reference
    https://powo.science.kew.org
  17. Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
    https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
  18. Talwar, A., Estes, E., Aparasu, R. and Reddy, D.S (2022) 'Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis', Experimental Neurology, 359, pp. 114238. doi:10.1016/j.expneurol.2022.114238 Meta-analysis / review
    https://doi.org/10.1016/j.expneurol.2022.114238
  19. Caus, M.N., Lupoae, M. and Chitescu, C.L (2026) 'Efficacy and Safety of Herbal Supplements with Anxiolytic, Antidepressant, and Sedative Action: A Review of Clinical Data and Toxicological Risks', Pharmaceuticals, 19(3), pp. 399. doi:10.3390/ph19030399 Meta-analysis / review
    https://doi.org/10.3390/ph19030399
  1. Shara, M. and Stohs, S.J (2015) 'Efficacy and Safety of White Willow Bark (Salix alba) Extracts', Phytotherapy Research, 29(8), pp. 1112-1116. doi:10.1002/ptr.5377 Meta-analysis / review
    https://doi.org/10.1002/ptr.5377
  2. Maistro, E.L., Terrazzas, P.M., Perazzo, F.F., Gaivao, I.O.M. and others (2020) 'Salix alba (white willow) medicinal plant presents genotoxic effects in human cultured leukocytes', Journal of Toxicology and Environmental Health, Part A, 82(23-24), pp. 1223-1234. doi:10.1080/15287394.2019.1711476 Preclinical
    https://doi.org/10.1080/15287394.2019.1711476
  3. Matyjaszczyk, E. and Schumann, R. (EU-FORA) (2018) 'Risk assessment of white willow (Salix alba) in food', EFSA Journal, 16(Suppl 1), pp. e16081. doi:10.2903/j.efsa.2018.e16081 Meta-analysis / review
    https://doi.org/10.2903/j.efsa.2018.e16081
  4. Phillips, H.N., Sharpe, K.T., Endres, M.I. and Heins, B.J (2021) 'Effects of oral white willow bark (Salix alba) and intravenous flunixin meglumine on prostaglandin E2 in healthy dairy calves', JDS Communications, 3(1), pp. 49-54. doi:10.3168/jdsc.2021-0138 Preclinical
    https://doi.org/10.3168/jdsc.2021-0138
  5. Kong, C.S., Kim, K.H., Choi, J.S., Kim, J.E. and others (2014) 'Salicin, an extract from white willow bark, inhibits angiogenesis by blocking the ROS-ERK pathways', Phytotherapy Research, 28(8), pp. 1246-1251. doi:10.1002/ptr.5126 Preclinical
    https://doi.org/10.1002/ptr.5126
  6. Noleto-Dias, C., Ward, J.L., Bellisai, A., Lomax, C. and Beale, M.H (2018) 'Salicin-7-sulfate: A new salicinoid from willow and implications for herbal medicine', Fitoterapia, 127, pp. 166-172. doi:10.1016/j.fitote.2018.02.009 Preclinical
    https://doi.org/10.1016/j.fitote.2018.02.009
  7. Wolfle, U., Haarhaus, B., Kersten, A., Fiebich, B. and others (2015) 'Salicin from Willow Bark can Modulate Neurite Outgrowth in Human Neuroblastoma SH-SY5Y Cells', Phytotherapy Research, 29(10), pp. 1494-1500. doi:10.1002/ptr.5400 Preclinical
    https://doi.org/10.1002/ptr.5400
  8. Gagnier, J.J., van Tulder, M., Berman, B. and Bombardier, C (2006) 'Herbal medicine for low back pain (Cochrane review)', Cochrane Database of Systematic Reviews, (2), pp. CD004504. doi:10.1002/14651858.CD004504.pub3 Meta-analysis / review
    https://doi.org/10.1002/14651858.CD004504.pub3
  9. Oltean, H., Robbins, C., van Tulder, M.W., Berman, B.M. and others (2014) 'Herbal medicine for low-back pain (Cochrane review update)', Cochrane Database of Systematic Reviews, 2014(12), pp. CD004504. doi:10.1002/14651858.CD004504.pub4 Meta-analysis / review
    https://doi.org/10.1002/14651858.CD004504.pub4
  10. Amel Zabihi, N., Mahmoudabady, M., Soukhtanloo, M., Hayatdavoudi, P. and others (2018) 'Salix alba attenuated oxidative stress in the heart and kidney of hypercholesterolemic rabbits', Avicenna Journal of Phytomedicine, 8(1), pp. 63-72. Preclinical
    https://scholar.google.com/scholar?q=Salix%20alba%20attenuated%20oxidative%20stress%20in%20the%20heart%20and%20kidney%20of%20hypercholesterolemic%20rabbits
  11. Vlachojannis, J.E., Cameron, M. and Chrubasik, S (2009) 'A systematic review on the effectiveness of willow bark for musculoskeletal pain', Phytotherapy Research. doi:10.1002/ptr.2747 Meta-analysis / review
    https://doi.org/10.1002/ptr.2747
  12. European Medicines Agency (HMPC) (n.d.) 'European Union herbal monograph on Salix [various species], cortex (Salicis cortex)'. Available at: https://www.ema.europa.eu/en/medicines/herbal/salicis-cortex Traditional / reference
    https://www.ema.europa.eu/en/medicines/herbal/salicis-cortex
  13. Chrubasik, S., Eisenberg, E., Balan, E., Weinberger, T., Luzzati, R. and Conradt, C (2000) 'Treatment of low back pain exacerbations with willow bark extract: a randomized double-blind study', The American Journal of Medicine, 109(1), pp. 9--14. doi:10.1016/S0002-9343(00)00442-3 Randomized trial
    https://doi.org/10.1016/S0002-9343(00)00442-3

Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.